Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Pseudotumor Cerebri Companies

ID: MRFR/Pharma/4254-HCR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is a condition characterized by increased pressure within the skull without the presence of a tumor. Companies involved in the field of pseudotumor cerebri may focus on various aspects, including diagnostics, treatments, and supportive measures.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pseudotumor Cerebri Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.15%
2024 Market Size$ 4.04 Billion
2025 Market Size$ 4.33 Billion
2035 Market Size$ 8.64 Billion
Key Players
Bristol-Myers Squibb
Novartis
Roche
Teva Pharmaceutical Industries
Eli Lilly and Company
Pfizer
Opportunities
  • Development of Novel Therapeutics
  • Growing Focus on Patient-Centric Care
  • Enhanced Diagnostic Imaging Techniques

Top Industry Leaders in the Pseudotumor Cerebri Market

Pseudotumor Cerebri Key Companies
 
Latest Pseudotumor Cerebri Companies Update

Avkare company specializing in IIH diagnostic tools is conducting a clinical trial comparing the accuracy of their MRI-based intracranial pressure (ICP) measurement device to the gold standard lumbar puncture. Positive results could significantly improve IIH diagnosis and treatment pathways.

Biogen is evaluating their anti-CGRP (calcitonin gene-related peptide) drug, rimegepant, in a Phase 3 clinical trial for patients with chronic IIH and refractory headaches. This could offer a non-surgical treatment option for IIH patients.

Actelion Pharmaceuticals (acquired by Janssen Pharmaceuticals) company focuses on drugs for rare diseases, including PTC. They are collaborating with patient advocacy groups and research institutions to advance IIH research and treatment options.

List of Pseudotumor Cerebri Key Companies in the Market

  • Avkare,
  • Beckersmith Medical Inc
  • Corporation
  • Johnson & Johnson Services
  • MercuryPharma
  • Phoenix Biomedical Corp
  • Novast Holdings Ltd
  • West-ward Pharmaceutical
  • Magstim
  • Integra Lifesciences
  • Braun Melsungen
  • Teva Pharmaceutical industries Ltd
  • Lannett Company
  • Elekta AB
  • Heritage Pharmaceuticals Inc